Cisplatin and etoposide in childhood germ cell tumor: Brazilian pediatric oncology society protocol GCT-91

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1297-1303

  Lopes, Luiz Fernando ^a   Macedo, Carla Renata Pacheco ^a   Pontes, Elitânia Marinho ^a   Aguiar, Simone Dos Santos ^a   Mastellaro, Maria Jose ^a   Melaragno, Renato ^a   Vianna, Sonia Maria Rossi ^a   Lopes, Paula Azevedo Allemand ^a   Mendonça, Nubia ^a   De Almeida, Maria Teresa Assis ^a   Sonaglio, Viviane ^a   Ribeiro, Karina B ^a   Santana, Victor M ^a   Schneider, Dominik T ^a   De Camargo, Beatriz ^a  

^a Sociedade Brasileira de Oncologia Pediátrica ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; VINBLASTINE;

ADOLESCENT; ARTICLE; BRAZIL; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; FEMALE; GERM CELL TUMOR; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; OTOTOXICITY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; SURVIVAL RATE;

EID: 62449121689     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.4202     Document Type: Article

References (25)

1. Young JL, Ries LG, Silverberg E, et al: Cancer incidence, survival and mortality for children younger than age 15 years. Cancer 58:598-602, 1986 (suppl 2)
2. Margolin K, Doroshow JH, Ahn C, et al: Treatment of germ cell cancer with two cycles of high-dose ifosf-amide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol 14:2631-2637, 1996
3. Göbel U, Schneider DT, Calaminus G, et al: Germ-cell tumors in childhood and adolescence. Ann Oncol 11:263-271, 2000
4. Hainsworth JD, Willaims SD, Einhorn LH, et al: Successful treatment of resistant germinal neoplasms with VP-16-213 and cisplatin: Results of a Southeastern Cancer Study Group trial. J Clin Oncol 3:666-671, 1985
5. Bosl GJ, Yagoda A, Golbey RB, et al: Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumor. Am J Med 78:423-428, 1985
6. Mann JR, Pearson D, Barrett A, et al: Results of the United Kingdom Children's Cancer Study Group's malignant germ-cell tumor studies. Cancer 63:1657-1667, 1989
7. Samuels ML, Holoye PY, Johnson DE: Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer 36:318-326,1975
8. Eigen H, Wyszomierski D: Bleomycin lung injury in children. Am J Pediatr Hematol Oncol 7:71-78, 1985
9. Kottmeir HL: Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 50:1-7, 1971
10. Exelby PR: Testicular cancer in children. Cancer 45:1803-1809, 1980
11. Lopes LF, de Camargo B, Dondonis M, et al: Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian Germ Cell Tumor Study. Med Pediatr Oncol 25:396-399, 1995
12. Lopes LF, Chazan R, Sredni ST, et al: Endodermal sinus tumor of the vagina in children. Med Pediatr Oncol 32:377-381, 1999
13. Mostofi FK, Sobin LH: Histological Typing of Testis Tumors. Geneva, Switzerland, World Health Organization, 1933
14. Gonzalez-Crussi F, Winkler RF, Mirkin DL: Sacrococcygeal teratomas in infants and children: Relationship of histology and prognosis in 40 cases. Arch Pathol Lab Med 102:420-425, 1978
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481,1958
16. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
17. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
18. Brandalise S, Odone V, Pereira W, et al: Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and-85. ALL Brazilian Group Leukemia 7:S142-S145, 1993 (suppl 2)
19. de Camargo B, de Andrea ML, Franco EL: Catching up with history: Treatment of Wilms' tumor in a developing country. Med Pediatr Oncol 15:270-276, 1987
20. Bokemeyer C, Schleucher N, Metzner B, et al: First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: A prospective trial. Br J Cancer 89:29-35, 2003
21. Kondagunta GV, Bacik J, Bajorin D, et al: Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. J Clin Oncol 23:9290-9294, 2005
22. Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 11:598-606, 1993
23. Cushing B, Giller R, Cullen JW, et al: Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study-Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 22:2691-2700, 2004
24. Rogers PC, Olson TA, Cullen JW, et al: Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22:3563-3569, 2004
25. Schlatter M, Rescorla F, Giller R, et al: Excellent outcome in patients with stage I germ cell tumors of the testes: A study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg 38:319-324, 2003